QR-koodi

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Täydet tiedot

Tallennettuna:
Päätekijät: Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2023-02-01
Sarja:Frontiers in Surgery
Aiheet:
low-grade glioma (WHO grade II)
cost
resection
stereotactic biopsy
adverse events—complications
MarketScan database
Linkit:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia